Multiple Sclerosis Clinical Trial
Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders
Participants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the extent to which VR can be used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR methods and collect preliminary data in order to support research grants and inform larger clinical trials. Additionally, this proposed study will explore the tolerability and preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can acutely reduce the severity of symptom burden caused by neurological disorders.
18-79 years of age
Has been diagnosed by a clinician as having MS
Able to commit to the designated period of testing
Able to understand the informed consent process and provide consent to participate in the study
Capacity to complete study procedures as determined by screening personnel
A Brief Pain Inventory interference score of at least 3 or more.
SDMT Z-Score > -3.0
WRAT4 Standard Score > or = 85
Visual, auditory, and motor deficits that would prevent full ability to understand study
Visual, auditory, and motor deficits that would prevent full ability to operate VR equipment
Current diagnosis of vertigo
Uncontrolled mood disorders
History of Psychosis or Schizophrenia
Expanded Disability Status Scale (EDSS) Score greater than 6.5
Unable to tolerate or manipulate VR treatment procedures (as evidenced by VR capability assessment)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10016, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.